Search

Your search keyword '"Sung, Anthony D."' showing total 274 results

Search Constraints

Start Over You searched for: Author "Sung, Anthony D." Remove constraint Author: "Sung, Anthony D." Search Limiters Full Text Remove constraint Search Limiters: Full Text
274 results on '"Sung, Anthony D."'

Search Results

1. Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus

2. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients

6. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

8. Clinical and Neuroimaging Correlates of Post-Transplant Delirium

12. The gut microbiota is associated with immune cell dynamics in humans

13. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease

14. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood

16. Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years

17. Home-Based Hematopoietic Cell Transplantation in the United States

23. A pilot study to assess the feasibility of a remotely monitored high-intensity interval training program prior to allogeneic hematopoietic stem cell transplantation.

24. Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults

25. Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease

26. Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation

27. Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients

28. Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease

29. Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation

30. Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia

31. Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients

32. DART: Distance Assisted Recursive Testing.

33. MI-Immune/1801: Lessons from an Ongoing, Multi-Center Trial Involving Biospecimen Collection for Prospective Microbiome and Immune Profiling in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

34. Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center

35. Correlation of Engraftment and Time from Melphalan Administration to Stem Cell Infusion

36. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant

39. Female Gender Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplant

40. Morphologic Leukemia-Free State in Acute Myeloid Leukemia Is Sufficient for Successful Allogeneic Hematopoietic Stem Cell Transplant

41. Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality

43. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

44. Microtransplantation in older patients with AML : A pilot study of safety, efficacy and immunologic effects

45. Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) Tool

46. Cognitive Impairment in Candidates for Allogeneic Hematopoietic Stem Cell Transplantation

47. Clinical and Neuroimaging Predictors of Post-Transplant Delirium

48. Phase II Trial of Pasireotide to Prevent GI Toxicity and Acute Gvhd in Allogeneic HSCT

49. Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients

50. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant

Catalog

Books, media, physical & digital resources